United InnoMed

Company Deals

United InnoMed Closes RMB 100 Million Series B+ Funding for Heart Failure Devices

Fineline Cube Apr 23, 2025

Shanghai-based United InnoMed, a developer of Class III active implantable medical devices, has closed a...

Company Drug

Novo Nordisk semaglutide Alzheimer’s biomarkers fail primary endpoint

Company Medical Device

Acotec V-otter Microcatheter Secures NMPA Approval for TACE Procedures

Company Deals

Youjia-Bio Tongee-Medical Nucleic-Acid-Drug Partnership Targets Diabetes

Company Drug

Fosun-Pharma FXS0887 ATR-Inhibitor Gets NMPA Phase 1 Nod